Legal Representation
Attorney
Paul D. Tietz
USPTO Deadlines
Next Deadline
506 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-12-22)
Due Date
December 22, 2026
Grace Period Ends
June 22, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
21 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Dec 22, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Nov 14, 2020 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
Nov 13, 2020 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
Nov 13, 2020 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
Nov 13, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Oct 29, 2020 | IUAF | S | USE AMENDMENT FILED | Loading... |
Oct 29, 2020 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
Jul 28, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Jun 2, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jun 2, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
May 13, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Apr 27, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
Apr 17, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Apr 17, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Apr 17, 2020 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
Apr 17, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Apr 17, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Apr 16, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Feb 4, 2020 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
Feb 3, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jan 31, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Biochemicals, namely, monoclonal and polyclonal antibodies for in vitro, in vivo, and ex vivo scientific and research use; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro, in vivo, and ex vivo diagnostic use
First Use Anywhere:
Feb 20, 2020
First Use in Commerce:
Feb 20, 2020
Additional Information
Design Mark
The mark consists of two parallel vertical lines that split at the top with two sets of small diagonal parallel lines on side of the top of each line with one of the small lines below and parallel to the angled portion of the two vertical lines and the other appearing as an extension of the angled portion of the two vertical lines representing a schematic illustration of an antibody projecting upwardly out of an open-topped circle.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
001